Ita-as, Dante U.

HRN: 26-51-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/01/2025
05/14/2025
IVTT
4.5g
Q8
Aspiration Pneumonia; T/c Sepsis
Waiting Final Action 
05/07/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/07/2025
05/13/2025
TOPICAL
1%
BID
Bed Sore
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: